Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer

被引：0
|
作者：
Muller, Marius [1 ]
Battisti, Umberto [1 ]
Shalgunov, Vladimir [1 ]
Jorgensen, Jesper [1 ]
Hvass, Lars [1 ]
Kramer, Vasko [2 ]
Kjaer, Andreas [1 ]
Herth, Matthias [1 ]
机构：
[1] Univ Copenhagen, Copenhagen, Denmark
[2] Positronpharma SA, Santiago, Chile
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
关键词：
BREAST-CANCER; TRASTUZUMAB; METASTASES; ONCOGENE;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-287
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [1] Synthesis and in vivo evaluation of [11C]tucatinib for HER2-targeted PET imaging
    Mueller, Marius
    Shalgunov, Vladimir
    Hvass, Lars
    Jorgensen, Jesper T.
    Kramer, Vasko
    Staudt, Markus
    Battisti, Umberto Maria
    Kjaer, Andreas
    Herth, Matthias M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 80
  • [2] Is there room for another HER2-targeting drug?
    Gianni, Luca
    LANCET ONCOLOGY, 2018, 19 (07): : 847 - 849
  • [3] Perspectives of HER2-targeting in gastric and esophageal cancer
    Gerson, James N.
    Skariah, Sam
    Denlinger, Crystal S.
    Astsaturov, Igor
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (05) : 531 - 540
  • [4] EVOLUTION OF HER2-TARGETING IN METASTATIC BREAST CANCER
    Bartsch, Rupert
    Balic, Marija
    BREAST CARE, 2022, 17 (06) : 521 - 522
  • [5] [11C]NS8880, a promising PET radiotracer targeting the norepinephrine transporter
    Vase, Karina H.
    Peters, Dan
    Nielsen, Elsebet O.
    Alstrup, Aage K. O.
    Bender, Dirk
    NUCLEAR MEDICINE AND BIOLOGY, 2014, 41 (09) : 758 - 764
  • [6] 11C labelling of AG957 -: a potential tyrphostin radiotracer for PET
    Ackermann, U
    Tochon-Danguy, HJ
    Young, K
    Sachinidis, JI
    Chan, JG
    Scott, AM
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2002, 45 (02): : 157 - 165
  • [7] Listeriolysin O enhances cytoplasmic delivery by HER2-targeting liposomes
    不详
    NANOMEDICINE, 2011, 6 (02) : 314 - 314
  • [8] Resistance mechanisms to HER2-targeting treatment in HER2-positive gastric cancer
    Kang, Kyo Hwa
    Nam, Ah-Rong
    Park, Ji Eun
    Bang, Ju-Hee
    Ling, Jin
    Jin, Mei Hua
    Kim, Tae Yong
    Han, Sae-Won
    Song, Sang-Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Oh, Do-Youn
    Bang, Yung-Jue
    CANCER RESEARCH, 2015, 75
  • [9] In vitro modeling of HER2-targeting therapy in disseminated prostate cancer
    Andersson, Jennie
    Rosestedt, Maria
    Asplund, Veronika
    Yavari, Nazila
    Orlova, Anna
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (05) : 2153 - 2158
  • [10] [11C]GMOM AS NEW POTENTIAL PET RADIOTRACER TO IMAGE THE NMDA RECEPTOR IN VIVO
    van der Doef, Thalia F.
    Golla, Sandeep V. S.
    Klein, Pieter J.
    Schuit, Robert C.
    Windhorst, Bert D.
    Lammertsma, Adriaan A.
    van Berckel, Bart N. M.
    Boellaard, Ronald
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S375 - S376
12345